Literature DB >> 33263260

The validity of the 'General Practice Physical Activity Questionnaire' against accelerometery in patients with chronic kidney disease.

Thomas J Wilkinson1,2, Jared Palmer1, Eleanor F Gore1, Alice C Smith1,2.   

Abstract

BACKGROUND: The majority of patients with chronic kidney disease (CKD) are physically inactive. Simple yet accurate assessment of physical activity is important in identifying those in need of intervention. The 'General Practice Physical Activity Questionnaire' (GPPAQ) is a well-used clinical and research tool, but has not been validated.
METHODS: Forty individuals with CKD (age 62.5 (SD: 11.1) years, estimated glomerular filtration rate (eGFR) 33.2 (SD:19.1) ml/min/1.73 m2) completed the GPPAQ and objective physical activity was measured using a GENEActiv accelerometer for 7 days. Physical activity status was grouped as 'Active' (i.e. meeting current physical activity UK guidelines) or 'Inactive.' Sensitivity and specificity were calculated. Accuracy was defined as the probability the GPPAQ could correctly classify a patient as either 'Active' or 'Inactive' (based on accelerometery).
RESULTS: Using accelerometery, 18% of participants met the current UK guidelines, whereas 27% were classed as 'Active' according to GPPAQ. Sensitivity of the GPPAQ was 54.6% and specificity was 96.6%. The 'accuracy' of the GPPAQ was 85.0%. The accuracy of the GPPAQ was greater in males and those not in employment/retired, although these differences were not statistically significant.
CONCLUSIONS: The GPPAQ may be a useful tool to identify CKD patients who would benefit most from a physical activity intervention. In particular, the GPPAQ can accurately identify those not sufficiently active.

Entities:  

Keywords:  Physical activity; accelerometry; kidney disease

Mesh:

Year:  2020        PMID: 33263260     DOI: 10.1080/09593985.2020.1855684

Source DB:  PubMed          Journal:  Physiother Theory Pract        ISSN: 0959-3985            Impact factor:   2.176


  2 in total

1.  The Feasibility and User-Experience of a Digital Health Intervention Designed to Prevent Weight Gain in New Kidney Transplant Recipients-The ExeRTiOn2 Trial.

Authors:  Ellen M Castle; Giulia Dijk; Elham Asgari; Sapna Shah; Rachel Phillips; James Greenwood; Kate Bramham; Joseph Chilcot; Sharlene A Greenwood
Journal:  Front Nutr       Date:  2022-05-23

2.  Cultural influences on physical activity and exercise beliefs in patients with chronic kidney disease: 'The Culture-CKD Study'-a qualitative study.

Authors:  Juliet Mayes; Ellen M Castle; James Greenwood; Paula Ormandy; P David Howe; Sharlene A Greenwood
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.